Khalifa S
Int Urol Nephrol. 2023; 55(10):2473-2481.
PMID: 37338655
PMC: 10499727.
DOI: 10.1007/s11255-023-03667-1.
Inzoli E, Aroldi A, Piazza R, Gambacorti-Passerini C
Am J Hematol. 2022; 97(8):1075-1085.
PMID: 35384030
PMC: 9546318.
DOI: 10.1002/ajh.26556.
Bowers R, Jones C, Paz E, Barrows J, Armeson K, Long D
Nucleic Acids Res. 2022; 50(7):3673-3692.
PMID: 35380699
PMC: 9023287.
DOI: 10.1093/nar/gkac200.
Balatti V, Croce C
Cancers (Basel). 2022; 14(3).
PMID: 35158777
PMC: 8833386.
DOI: 10.3390/cancers14030509.
Asuzu D, Desai B, Maggio D, Mandell J, Ray-Chaudhury A, Abdullaev Z
J Spine Surg. 2021; 7(3):434-438.
PMID: 34734147
PMC: 8511564.
DOI: 10.21037/jss-21-24.
Advent of CRISPR Based Immunotherapy in Hematologic Malignancies.
Perez R, Chen R, Kang R, Perez A
J Oncopathol Clin Res. 2018; 2(1).
PMID: 29953127
PMC: 6018007.
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib.
Redaelli S, Perini P, Ceccon M, Piazza R, Rigolio R, Mauri M
J Hematol Oncol. 2015; 8:81.
PMID: 26149173
PMC: 4491863.
DOI: 10.1186/s13045-015-0179-4.
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.
Cruceru M, Neagu M, Demoulin J, Constantinescu S
J Cell Mol Med. 2013; 17(10):1218-35.
PMID: 23998913
PMC: 4159024.
DOI: 10.1111/jcmm.12122.
Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date.
Lowe E, Lim M
Paediatr Drugs. 2013; 15(3):163-9.
PMID: 23696342
PMC: 4267854.
DOI: 10.1007/s40272-013-0027-3.
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study.
Maynadie M, De Angelis R, Marcos-Gragera R, Visser O, Allemani C, Tereanu C
Haematologica. 2012; 98(2):230-8.
PMID: 22983589
PMC: 3561430.
DOI: 10.3324/haematol.2012.064014.
Drug discovery prospect from untapped species: indications from approved natural product drugs.
Zhu F, Ma X, Qin C, Tao L, Liu X, Shi Z
PLoS One. 2012; 7(7):e39782.
PMID: 22808057
PMC: 3394748.
DOI: 10.1371/journal.pone.0039782.
Dynamics of targeted cancer therapy.
Bozic I, Allen B, Nowak M
Trends Mol Med. 2012; 18(6):311-6.
PMID: 22595628
PMC: 3372676.
DOI: 10.1016/j.molmed.2012.04.006.
A review on various targeted anticancer therapies.
Li J, Chen F, Miranda Cona M, Feng Y, Himmelreich U, Oyen R
Target Oncol. 2012; 7(1):69-85.
PMID: 22350489
DOI: 10.1007/s11523-012-0212-2.
Optical, structural and thermodynamic studies of the association of an anti-leucamic drug imatinib mesylate with transport protein.
Hegde A, Punith R, Seetharamappa J
J Fluoresc. 2011; 22(1):521-8.
PMID: 21947613
DOI: 10.1007/s10895-011-0986-0.
Bioinformatics challenges for personalized medicine.
Fernald G, Capriotti E, Daneshjou R, Karczewski K, Altman R
Bioinformatics. 2011; 27(13):1741-8.
PMID: 21596790
PMC: 3117361.
DOI: 10.1093/bioinformatics/btr295.
